Abstract
Background and objectives: New technologies provide the opportunity to understand the complex systemic background of multidimensional diseases and allow for a personalised approach. Continuous glucose monitoring (CGM) sensors and their broad use have been key in the discovery of the metabolic heterogeneity surrounding many disorders such as diabetes type II, and have placed the scientific community a step closer to determining which factors contribute to their complications and evolution. However, gathering data extending beyond glucose levels linked to lifestyle factors, such as nutrition, physical activity, sleep quality, and stress, poses a significant challenge in terms of representation, considering the substantial amount of data involved. To comprehend the relationship between these variables in a practical manner that empowers individuals to make choices enhancing their quality of life, there is a need for new graphics. These graphics would enable the observation of the overall framework in a contextualised manner and assist in establishing clear visual goals. Methods: This article introduces glycaemic matrix and metabolic segmentation, a new method for representing and evaluating functional profiles by combining glucose and lifestyle data. Results: In this early-phase trial, the potential of this approach to represent the complete glycaemic spectrum within its context and adapt to a diverse range of objectives is demonstrated. Discussion: We propose a promising tool to finally be able to cluster metabolic types through artificial intelligence (AI) and adapt clinical interventions to metabolic heterogeneity. This research is private research conducted under Glucovibes company R&D initiatives.
Author Contributions
Conceptualization, N.A. and A.C.M.; Methodology, N.A. and A.C.M.; Validation, L.F. and A.C.M.; Investigation, N.A. and A.C.M.; Data curation, analysis and visualization, N.A.; Manuscript writing, preparation, review, revision and submission, N.A., L.F. and A.C.M. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by Glucovibes company.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The data that support the findings of this study are not publicly available due to privacy, commercialization, and/or ethical restrictions. However, data can be made available upon request from the corresponding author.
Conflicts of Interest
All authors were employed by Glucovibes company.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).